Envarsus Pa 1 mg (Tacrolimus TABLET (EXTENDED-RELEASE)) 1 MG

ENVARSUS PA 1 MG is an extended-release tablet containing tacrolimus, used for immunosuppression. This medication helps prevent organ rejection post-transplant. Learn more about ENVARSUS PA 1 MG uses and effects.

Strength

1 MG

Manufacturer / TM Owner

ENDO OPERATIONS LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ENVARSUS PA 1 MG is primarily used to prevent organ rejection in patients who have received a liver or kidney transplant. Tacrolimus, the active ingredient, works by suppressing the immune system to reduce the risk of rejection. This medication is often prescribed as part of a broader treatment plan following transplant surgery. ENVARSUS PA 1 MG tablets are designed for extended-release, ensuring a steady level of the drug in the body.

Side Effects

Common effects of ENVARSUS PA 1 MG may include headaches, tremors, and gastrointestinal issues such as nausea or diarrhea. Some users might experience changes in blood pressure or blood sugar levels. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

ENVARSUS PA 1 MG should be handled with care, especially regarding dosage and administration. It is crucial to follow the prescribed regimen and avoid sudden changes without medical advice. This medication should be stored at room temperature, away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Avoid Interactions

ENVARSUS PA 1 MG may interact with various medications, including those that affect the liver's cytochrome P450 system. Common interactants include certain antibiotics, antifungals, and heart medications. Alcohol and other immunosuppressants should be used with caution. Always consult a healthcare provider before starting or stopping any medication while on ENVARSUS PA 1 MG.

Frequently Asked Questions

ENVARSUS PA 1 MG is used to prevent organ rejection in patients who have received a liver or kidney transplant.

ENVARSUS PA 1 MG should be taken orally, exactly as prescribed by your healthcare provider. It is an extended-release tablet, so it should not be crushed or chewed.

Common side effects may include headaches, tremors, nausea, and diarrhea. Always consult a healthcare provider for any concerns.

ENVARSUS PA 1 MG may interact with other medications, so it's important to consult a healthcare provider before combining it with any other drugs.

If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not double the dose to catch up.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.